Focused protein degradation is getting explored as an alternative technique in cancer, whereby the natural protein degradation technique is co-opted for therapeutic needs. Not too long ago formulated novel molecules termed proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. One particular ligand binds on the https://www.directivepublications.org/journal-of-clinical-breast-cancer/